Department of Immunology, Binzhou Medical University, Yantai, China.
Department of Ophthalmology, Yuhuangding Hospital, Yantai, China.
J Cell Mol Med. 2019 Mar;23(3):1827-1839. doi: 10.1111/jcmm.14081. Epub 2018 Dec 8.
Natural killer (NK) cells have been reported to play a pathological role in autoimmune uveitis. However, the mechanisms regarding NK cells in uveitis and factors that affect NK-cell activation in this condition remain unclear. Here, we report that the number of CD3 NK1.1 CD83 CCR7 cells is increased in the inflamed eyes within a mouse model of experimental autoimmune uveitis (EAU), and these cells express elevated levels of NKG2D, CD69 and IFN-γ. Adoptively transferring CD83 CCR7 NK cells aggravates EAU symptoms and increases the number of CD4 IFN-γ T cells and dendritic cells (DCs) within the eye. These CD83 CCR7 NK cells then promote the maturation of DCs and IFN-γ expression within T cells as demonstrated in vitro. Furthermore, IL-18, as primarily secreted by DCs in the eyes, is detected to induce CD83 CCR7 NK cells. In EAU mice, anti-IL-18R antibody treatment also decreases retinal tissue damage, as well as the number of infiltrating CD83 CCR7 NK cells, T cells and DCs in the inflamed eyes and spleens of EAU mice. These results suggest that CD83 CCR7 NK cells, as induced by IL-18 that primarily secreted by DCs, play a critical pathological role in EAU. Anti-IL-18R antibody might serve as a potential therapeutic agent for uveitis through its capacity to inhibit CD83 CCR7 NK cells infiltration.
自然杀伤 (NK) 细胞已被报道在自身免疫性葡萄膜炎中发挥病理性作用。然而,关于葡萄膜炎中 NK 细胞的机制以及影响该条件下 NK 细胞激活的因素仍不清楚。在这里,我们报告在实验性自身免疫性葡萄膜炎 (EAU) 的小鼠模型中,炎症眼睛中的 CD3 NK1.1 CD83 CCR7 细胞数量增加,这些细胞表达高水平的 NKG2D、CD69 和 IFN-γ。过继转移 CD83 CCR7 NK 细胞可加重 EAU 症状,并增加眼内 CD4 IFN-γ T 细胞和树突状细胞 (DC) 的数量。这些 CD83 CCR7 NK 细胞随后促进 DC 的成熟和 T 细胞中 IFN-γ 的表达,这在体外得到证实。此外,IL-18 主要由眼内的 DC 分泌,被检测到可诱导 CD83 CCR7 NK 细胞。在 EAU 小鼠中,抗 IL-18R 抗体治疗还可减轻视网膜组织损伤,以及炎症眼睛和 EAU 小鼠脾脏中浸润的 CD83 CCR7 NK 细胞、T 细胞和 DC 的数量。这些结果表明,由 DC 主要分泌的 IL-18 诱导的 CD83 CCR7 NK 细胞在 EAU 中发挥关键的病理性作用。抗 IL-18R 抗体可能通过抑制 CD83 CCR7 NK 细胞浸润成为葡萄膜炎的一种潜在治疗药物。